Skip to main content
Year archive

Mendus — 2022 filings

All 33 regulatory filings released by Mendus (IMMU) in 2022, sourced directly from the official regulator.

33 Filings
2022 Period
2022 filings (33)
Filing Released Lang
Mendus AB: Mendus presents positive survival data from the ADVANCE II trial evaluating DCP-001 as a maintenance therapy in AML at the American Society of Hematology (ASH) meeting
Earnings Release FY 2022
2022-12-12 English
Mendus AB: Mendus presenterar positiva överlevnadsdata från ADVANCE II-studien, som utvärderar DCP-001 som underhållsbehandling vid AML, på American Society of Hematology (ASH)
Earnings Release FY 2022
2022-12-12 Swedish
Mendus AB: Kommuniké från extra bolagsstämma i Mendus AB (publ) den 18 november 2022
AGM Information
2022-11-18 Swedish
Mendus AB: Report from the Extraordinary General Meeting of Mendus AB (publ) on 18 November 2022
AGM Information
2022-11-18 English
Earnings Release 2022
Earnings Release Q3 2022
2022-11-11 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Q3 2022
2022-11-11 English
Mendus AB: Mendus announces Nomination Committee for the 2023 Annual General Meeting
AGM Information
2022-11-10 English
Mendus AB: Mendus tillkännager valberedning inför årsstämman 2023
Board/Management Information
2022-11-10 Swedish
Mendus AB: Notice of extraordinary general meeting in Mendus AB (publ)
AGM Information
2022-10-26 English
Mendus AB: Kallelse till extra bolagsstämma i Mendus AB (publ)
Proxy Solicitation & Information Statement
2022-10-26 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Q2 2022
2022-08-26 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Q2 2022
2022-08-26 English
Mendus AB: Mendus tillkännager erhållande av finansieringsåtaganden på totalt upp till 250 miljoner kronor från Van Herk Investments och Negma Group
Capital/Financing Update
2022-08-26 Swedish
Mendus AB: Mendus announces financing commitments totaling up to SEK 250 million with Van Herk Investments and Negma Group
Capital/Financing Update
2022-08-26 English
Immunicum AB: Immunicum Announces Corporate Rebranding and Name Change to Mendus AB
Regulatory Filings
2022-06-23 English
Immunicum AB: Immunicum tillkännager Corporate Rebranding och namnbyte till Mendus AB
Regulatory Filings
2022-06-23 Swedish
Immunicum AB: Immunicum Announces Positive Interim Results from ADVANCE II Study in AML Maintenance Treatment
Earnings Release Q4 2022
2022-05-16 English
Immunicum AB: Immunicum tillkännager positiva interimsresultat från ADVANCE II-studie i AML-underhållsbehandling
Earnings Release Q4 2022
2022-05-16 Swedish
Immunicum AB: Kommuniké från årsstämma i Immunicum AB (publ) den 10 maj 2022
AGM Information
2022-05-10 Swedish
Immunicum AB: Report from the Annual General Meeting of Immunicum AB (publ) on 10 May 2022
AGM Information
2022-05-10 English
Earnings Release 2022
Earnings Release Q1 2022
2022-05-10 Swedish
Earnings Release 2022
Earnings Release Q1 2022
2022-05-10 English
Immunicum AB: Immunicum Appoints Leopold Bertea as Chief Technology Officer
Board/Management Information
2022-05-05 English
Immunicum AB: Immunicum utser Leopold Bertea till Chief Technology Officer
Board/Management Information
2022-05-05 Swedish
Annual Report (ESEF) 2021
Annual Report (ESEF) FY 2021
2022-04-15 Swedish
Annual Report (ESEF) 2021
Annual Report (ESEF) FY 2021
2022-04-15 Swedish
Immunicum AB: KALLELSE TILL ÅRSSTÄMMA I IMMUNICUM AB (PUBL)
AGM Information
2022-04-08 Swedish
Immunicum AB: Notice of Annual General Meeting in Immunicum AB (publ)
AGM Information
2022-04-08 English
Earnings Release 2021
Earnings Release Q4 2021
2022-02-18 Swedish
Earnings Release 2021
Earnings Release Q4 2021
2022-02-18 English
Regulatory Filings 2022
Regulatory Filings
2022-02-17 English
Immunicum Transfers Patent Rights for Modified Adenovirus to Elicera Therapeutics
Regulatory Filings
2022-01-05 English
Immunicum överför patenträttigheter för modifierat adenovirus till Elicera Therapeutics
Regulatory Filings
2022-01-05 Swedish